National Health Investors (NHI)
(Delayed Data from NYSE)
$71.33 USD
+1.47 (2.10%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $71.35 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NHI 71.33 +1.47(2.10%)
Will NHI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NHI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NHI
Xenia Hotels & Resorts (XHR) Tops Q2 FFO and Revenue Estimates
STRW or NHI: Which Is the Better Value Stock Right Now?
NHI: What are Zacks experts saying now?
Zacks Private Portfolio Services
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
Centerspace (CSR) Matches Q1 FFO Estimates
CUZ vs. NHI: Which Stock Is the Better Value Option?
Other News for NHI
National Health Investors Inc (NHI) Announces Q2 2025 Earnings Release and Conference Call | ...
NHI Announces Second Quarter 2025 Earnings Release and Conference Call Dates | NHI Stock News
Welltower: A Thriving Business With Strong Secular Tailwinds Selling At A Premium
National Health Investors (NHI) Receives Keybanc Upgrade and New Price Target | NHI Stock News
KeyBanc Upgrades National Health Investors (NHI) with Promising Outlook | NHI Stock News